MEDICAL DEVICES

Lark Health Builds AI-Driven Heart Health Program

Lark Health | March 17, 2022

Lark Health

Lark Health today announced the development of a novel AI-driven program for the prevention and management of atherosclerotic cardiovascular disease and coronary artery disease in collaboration with Roche Diagnostics. The program, named Lark Heart Health, is an AI-driven virtual care solution that provides personalized health coaching anytime, anywhere. The new Heart Health program is planned to launch later this year. 

Cardiovascular disease is the leading cause of death globally, and nearly half of all adults in the U.S. have some form of CVD. It's also one of the most expensive chronic conditions, with heart disease and stroke costing the U.S. healthcare system roughly $214 billion annually. Yet, provider shortages and siloed care teams leave patients with limited care options, gaps in care, and insufficient education and empowerment to self-manage their heart health. Additionally, high treatment costs and resource constraints often limit care to those with the highest acuity conditions.

Built using a Cognitive Behavioral Therapy framework and designed in accordance with guidelines from the American Heart Association (AHA), Lark Heart Health will provide a cost-effective, scalable solution for continuous, person-centric remote heart health coaching intended to help users improve their healthy lifestyle behaviors, reduce stress levels, and ultimately decrease risk factors for heart disease. Through an evidence-based educational curriculum and real-time personalized coaching, Lark will provide users with the tools they need to make meaningful lifestyle changes that can help them better prevent and manage ASCVD and CAD.

Earlier this year, Lark announced it had joined the AHA's Network at American Heart Association Center of Health Technology & Innovation, which is focused on building and fostering health technology relationships to develop innovative and scalable solutions.

"Lark Heart Health will help those at high risk prevent and actively manage cardiovascular disease through personalized digital coaching. By leveraging our AI technology, we can deliver meaningful and engaging care at an unprecedented scale, and this collaboration with Roche Diagnostics will support the expansion of our proven tech platform into one of the costliest chronic disease markets."

Julia Hu, co-founder and CEO of Lark

About Lark Health
Lark is a healthcare technology company aimed at delivering infinitely scalable, virtual chronic and preventative healthcare through conversational AI. To date, Lark has provided nearly 2 million people with unlimited, 24/7 personalized care delivered through an easy-to-use, text message-like interface that integrates remote patient monitoring tools and is built on a cognitive behavioral therapy framework. Lark's platform seamlessly integrates with health plans' and employers' existing healthcare infrastructure to help them scale their chronic disease prevention and management programs, boost engagement, and improve health outcomes. Lark currently works with many of the largest health plans and across four programs: Prevention, Diabetes Prevention, Diabetes Care, and Hypertension Care. Lark's Diabetes Prevention Program, which is the fastest growing and lowest cost DPP, has received the highest level of clinical recognition—Full Recognition—from the Centers for Disease Control and Prevention. The company has received numerous accolades, including having been named as one of CB Insights Digital Health 150 (2019), a finalist for the UCSF Digital Health Awards one of Fast Company's Most Innovative Companies and one of Fierce Healthcare's Fierce 15. 

Spotlight

This is the story of a nurse, who was treating my eighty year old father. He had suffered an incredible fall and was about to have his second back surgery in two weeks. My dad recognized the nurse caring for him and he joked that he was back after just a week. Upon hearing this, this nurse remarked, “Wow, I really don’t remember my patients.” At that point I noticed that she hadn’t introduced herself and she had her badge on backwards. I got her attention, and asked her name. She replied, "Well that depends, I will only tell you my name after you tell me if you think I am doing a good job." And she wasn’t joking. My trust level went to zero. I countered with, “My name is Barbara.” She eventually replied with, “My name is Cindy.” To this day, I wonder if Cindy was her real name. Her answer impacted my trust, but I also worried about what she might be experiencing. What was the culture like there and was that considered acceptable.

Spotlight

This is the story of a nurse, who was treating my eighty year old father. He had suffered an incredible fall and was about to have his second back surgery in two weeks. My dad recognized the nurse caring for him and he joked that he was back after just a week. Upon hearing this, this nurse remarked, “Wow, I really don’t remember my patients.” At that point I noticed that she hadn’t introduced herself and she had her badge on backwards. I got her attention, and asked her name. She replied, "Well that depends, I will only tell you my name after you tell me if you think I am doing a good job." And she wasn’t joking. My trust level went to zero. I countered with, “My name is Barbara.” She eventually replied with, “My name is Cindy.” To this day, I wonder if Cindy was her real name. Her answer impacted my trust, but I also worried about what she might be experiencing. What was the culture like there and was that considered acceptable.

Related News

HEALTH TECHNOLOGY

SimpleHealth Acquires Emme, Accelerating Its Digital Technology Innovation in Reproductive Healthcare

SimpleHealth | February 21, 2022

SimpleHealth, one of the nation’s fastest-growing reproductive healthcare companies, today announced the acquisition of Emme, a healthcare technology company focused on women's health. The acquisition expands SimpleHealth's birth control prescription delivery and telehealth services while addressing unmet needs in reproductive healthcare through a patient-centered approach. SimpleHealth provides convenient affordable access to birth control, and, with the addition of Emme’s proprietary, technology-driven system, expects to improve medication adherence for its patients. The Emme Smart Birth Control System is an integrated solution designed to lower the national 9% failure rate of birth control pills to reduce the number of unplanned pregnancies. “As SimpleHealth expands its focus to reach patients throughout the full reproductive life cycle, we are thrilled to join forces with Emme and offer their innovative technology solutions," said Carrie SiuButt, Chief Executive Officer, SimpleHealth. "Both Emme and SimpleHealth are pioneers in contraceptive care, and we are excited to bring in a company that has a strong position in healthcare technology. This acquisition will further solidify SimpleHealth's position as a vital platform for connected, personalized reproductive care." The transaction will accelerate SimpleHealth’s digital offerings, supporting rapid technology innovation expansion into key reproductive care categories to gain market share in a highly scalable way. Emme's connected Smart Birth Control System streamlines a patient's ability to receive, track, and manage birth control pills, safeguarding the process. The acquisition will empower SimpleHealth patients to control their health through access to a fully integrated and connected care experience that utilizes personalized data to improve outcomes and satisfaction. “We created the Emme Smart Birth Control System to provide a digital support system for patients and help reduce the rate of missed pills, which historically accounts for nearly one million unplanned pregnancies in the United States annually. SimpleHealth stands out unequivocally as the best company to partner with as we scale our offering thanks to their unparalleled commitment to healthcare accessibility, innovation, and our shared dedication to improving the standard of care in reproductive health.” Amanda French, co-founder and Chief Executive Officer of Emme French will join the SimpleHealth executive team as Chief Innovation Officer, leading the acceleration of SimpleHealth’s product offerings to patients. With this fusion of two women-led companies, SimpleHealth will deliver a new standard in connected care, leveraging its existing strength in reproductive and behavioral health to expand into fertility preparedness, perimenopause and other transitional life phases. Kluk Farber Law served as legal counsel to SimpleHealth, and Wilson Sonsini Goodrich & Rosati served as legal counsel to Emme. About SimpleHealth SimpleHealth is a nationally recognized telehealth and wellness provider offering convenient, simple and affordable access to birth control in the US. With a mission to break down the accessibility barriers in reproductive care, SimpleHealth offers fully integrated guidance through a network of medical experts and technology. From click to consult, SimpleHealth empowers everyone to control their healthcare experience at all stages of their life. About Emme Emme is the first company to offer a fully integrated birth control system for pill management. The Emme Smart Case and app is an integrated technology-enabled solution designed to safeguard the birth control experience and help reduce the rate of missed pills. The Emme Smart Case uses patented, multi-sensor technology to track when pills are taken, syncing with the app to send customized reminders and contraceptive information. Emme was founded at the Stanford Byers Center for Biodesign and named to 2021 lists for Fast Company's World's Most Innovative Companies and TIME’s Best Inventions.

Read More

HEALTH TECHNOLOGY

Endeavour Vision has closed Endeavour Medtech Growth II LP for USD 375 Million to Invest in Transformative Healthcare Technology

Endeavour Vision | April 23, 2021

Endeavour Vision today announced the closure of Endeavour Medtech Growth II (EMG II) LP at a total capital commitment of USD 375 million. The fund will follow the same approach as its predecessor, which was to help early-stage Medtech and digital health advances that advance the quality of care and improve healthcare system efficiencies. EMG II LP was funded by both current and returning investors, including public pension funds, multi-manager funds, family offices, and high-net-worth individuals. EMG II LP expands on Endeavour Vision's two decades of healthcare investment, which has resulted in over USD 500 million invested in 42 businesses, 21 of which have exited through acquisition or IPO. The fund's closure comes as the world prepares for post-pandemic existence after more than a year in the hands of COVID-19, a crisis that has driven the introduction of emerging healthcare technologies, including innovative methods of providing remote patient treatment. Underlying factors such as aging populations, chronic diseases, and tightening healthcare budgets will continue to drive appetite for cost-effective solutions. As a result, healthcare advancement is expected to remain a long-term focus, generating attractive growth and a rich range of opportunities for investors. The fund has now invested more than USD 100 million in seven companies: IntelyCare, CeQur, Rapid Micro Biosystems, SOPHiA GENETICS, Nalu Medical, Lumeon, and Relievant Medsystems. Endeavor Vision is one of the world's leading Medtech and digital health investment teams. The firm collaborates with game-changing businesses, aggressively assisting them with strategic and organizational experience to encourage their global success beyond finance. About Endeavour Vision Endeavour Vision, established in 2000, is a venture capital and growth equity company that invests in early-stage Medtech and digital health businesses in Europe and the United States. Its foreign investment teams are located in two major healthcare hubs in Geneva, Switzerland, and Minneapolis.

Read More

HEALTH TECHNOLOGY

Medallia Launches Healthcare Payer Member Retention and Engagement Suite

Medallia | August 18, 2021

Medallia, Inc. (NYSE: MDLA), the global leader in customer and employee experience, today announced the launch of the Medallia Healthcare Payer Member Retention and Engagement Suite. The Healthcare Payer Member Retention and Engagement Suite enables insurers to engage members at key moments during the journey by gathering instantaneous feedback and insights across all channels, surfacing insights to the appropriate teams, and providing recommended actions for a better member experience. “As it was for most businesses, the pandemic presented complex challenges for healthcare payers regarding coverage and access to care. Healthcare consumers are making decisions based on interactions with their insurers, in near real-time. This dynamic is forcing the industry to take a data-driven approach to engaging members at the right time, with the right message, via the right channel to create more valuable and trusting relationships, driving better long-term outcomes,” Steven Carleton, Vice President Customer Experience, Premera Blue Cross. The new offering from Medallia addresses a number of payer use cases and needs, helping payers: Improve engagement by listening, understanding, and responding to the needs of members Decrease churn by empowering teams to resolve friction in the journey and meet members in the moment Attract new members by delivering seamless and connected experiences with consumers Improve efficiencies and ease of doing business by optimizing digital communication channels “With increased competition in a price sensitive market, payers are finding new ways to differentiate themselves with consumers and members through improved experiences,” said Toni Land, Head of Clinical Healthcare Experience, Medallia. “Leveraging industry-leading experience management capabilities, Medallia partners with payers to help design and implement effective, scalable engagement programs with measurable outcomes.” The solution includes: Real-time feedback mechanism for capturing member experiences throughout the entire journey, whether in app, digital or over the phone SMS communication to find an appropriate care provider, manage the claims process, and engage members pre and post encounters Text analytics to identify themes and trends across the specific member populations with the use of AI and machine learning Video communication platform to prioritize high-risk members, address service recovery needs, and give members an opportunity to leave feedback throughout the process Speech analytics to surface insights from every conversation, combine with other channels for a complete member view, and address pain points in real time Digital engagement and analytics solution to enrich real-time experiences by cutting through noise to prioritize and address what matters most About Medallia Medallia (NYSE: MDLA) is the pioneer and market leader in customer, employee, citizen and patient experience. The company’s award-winning SaaS platform, Medallia Experience Cloud, is becoming the experience system of record that makes all other applications customer and employee aware. The platform captures billions of experience signals across interactions including all voice, video, digital, IoT, social media and corporate messaging tools. Medallia uses proprietary artificial intelligence and machine learning technology to automatically reveal predictive insights that drive powerful business actions and outcomes. Medallia customers reduce churn, turn detractors into promoters and buyers, create in-the-moment cross-sell and up-sell opportunities and drive revenue-impacting business decisions, providing clear and potent returns on investment.

Read More